Edition:
United States

Carl Zeiss Meditec AG (AFXG.DE)

AFXG.DE on Xetra

34.39EUR
11:35am EDT
Change (% chg)

€1.05 (+3.16%)
Prev Close
€33.33
Open
€33.58
Day's High
€34.58
Day's Low
€33.45
Volume
71,310
Avg. Vol
68,265
52-wk High
€37.57
52-wk Low
€24.30

AFXG.DE

Chart for AFXG.DE

About

Carl Zeiss Meditec AG is a Germany-based medical technology solutions supplier. The Company operates, along with its subsidiaries, in two business areas: Ophthalmology and Microsurgery. The Ophthalmology business area is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic... (more)

Overall

Beta: 0.26
Market Cap(Mil.): €2,710.46
Shares Outstanding(Mil.): 81.31
Dividend: 0.38
Yield (%): 1.14

Financials

  AFXG.DE Industry Sector
P/E (TTM): 34.91 45.28 36.51
EPS (TTM): 0.95 -- --
ROI: 9.11 7.63 13.85
ROE: 10.21 9.74 14.77

German stocks - Factors to watch on August 12

FRANKFURT, Aug 12 The DAX top-30 index looked set to open 0.1 percent lower on Friday, according to premarket data from brokerage Lang & Schwarz at 0607 GMT. The following are some of the factors that may move German stocks:

Aug 12 2016

BRIEF-Carl Zeiss Meditec names new chief for ophthalmology ops

* Carl Zeiss Meditec recruits James v. Mazzo to lead its newly consolidated ophthalmology organization Source text for Eikon: Further company coverage:

Jul 27 2016

German stocks - Factors to watch on July 15

FRANKFURT, July 15 The DAX top-30 index looked set to open 0.3 percent lower on Friday, according to premarket data from brokerage Lang & Schwarz at 0618 GMT.

Jul 15 2016

BRIEF-Carl Zeiss Meditec sees EBIT margin of 13-15 percent this year

* Says earnings before interest and taxes (ebit) also increased to eur 75 million in h1

May 11 2016

German stocks - Factors to watch on April 6

BERLIN/FRANKFURT, April 6 The DAX top-30 index looked set to open 0.3 percent higher on Wednesday, according to premarket data from brokerage Lang & Schwarz at 0607 GMT.

Apr 06 2016

BRIEF-Carl Zeiss Meditec sees EBIT rising this year

* Achieves revenue growth of approximately 9 pct in first half year 2015/16

Apr 04 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Wright Reports
$75.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : EQUI.TS
$10.00
Provider : EQUI.TS
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.